ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
0 hedge funds and large institutions have $0 invested in Avenue Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-7
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
IC
1
Ikarian Capital
Dallas,
Texas
| – | -$280K | -140,000 | Closed |
|
|
BFM
2
Boothbay Fund Management
New York
| – | -$82.2K | -41,089 | Closed |
|
3
UBS Group
Zurich,
Switzerland
| – | -$15.8K | -7,920 | Closed |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | -$6.19K | -3,096 | Closed |
|
5
Wells Fargo
San Francisco,
California
| – | -$1K | -500 | Closed |
|
6
Bank of America
Charlotte,
North Carolina
| – | -$28 | -14 | Closed |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| – | -$18 | -9 | Closed |
|